CAPRIN1 and cancer: Several studies have also demonstrated that the intracellular expression of CAPRIN-1 is positively correlated with cancer progression and poor prognosis, suggesting that CAPRIN-1 could be a diagnostic biomarker and a suitable cancer therapeutic target (12–19).